These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11474993)

  • 1. New avenues in surfactant research.
    Robertson B
    Z Geburtshilfe Neonatol; 2001; 205(3):77-8. PubMed ID: 11474993
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant and the neonatal lung.
    Gibson AT
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies.
    Coulter DM; Jung AL
    J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic surfactants in infants with respiratory distress syndrome.
    Perlman JM; Moya F
    N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug treatments of respiratory distress syndrome in premature infants].
    Saliba E; Laugier J
    Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant for respiratory distress syndrome.
    Bierman SF
    N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
    Enhorning G
    Pediatrics; 1980 Nov; 66(5):799-800. PubMed ID: 7432889
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic surfactant.
    Long W
    Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant replacement therapy: a second look.
    Lynam LE
    Neonatal Netw; 1990 Oct; 9(3):79-81. PubMed ID: 2215450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of idiopathic respiratory distress syndrome--prospective method by artificial surfactant (author's transl)].
    Kobayashi T; Sada T; Murakami S
    Masui; 1979 Oct; 28(10):1012-7. PubMed ID: 513270
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factors affecting clinical response to surfactant therapy in neonates with severe respiratory distress syndrome].
    Fujiwara T; Chida S; Konishi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):29-34. PubMed ID: 2041254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
    Chima RS; Zingarelli B
    Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome.
    Hallman M; Merritt TA; Schneider H; Epstein BL; Mannino F; Edwards DK; Gluck L
    Pediatrics; 1983 Apr; 71(4):473-82. PubMed ID: 6340042
    [No Abstract]   [Full Text] [Related]  

  • 14. Early surfactant in spontaneously breathing with nCPAP in ELBW infants--a single centre four year experience.
    Kribs A; Vierzig A; Hünseler C; Eifinger F; Welzing L; Stützer H; Roth B
    Acta Paediatr; 2008 Mar; 97(3):293-8. PubMed ID: 18298776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
    Jeng MJ
    Pediatr Neonatol; 2015 Aug; 56(4):211-2. PubMed ID: 25892643
    [No Abstract]   [Full Text] [Related]  

  • 16. RDS and surfactant replacement: the double-edged sword.
    Etherington H; Lawrence J; Davis D
    Can Nurse; 1993 Jan; 89(1):14-7. PubMed ID: 8425163
    [No Abstract]   [Full Text] [Related]  

  • 17. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study].
    Wauer RR; Schmalisch G; Rogalski M
    Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant therapy of premature infants. Complications and mortality are reduced].
    Hjalmarson O
    Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.